The enrollment phase of the STAR (Stimulation Therapy for Apnea Reduction) Trial is complete and the follow-up phase continues at leading medical centers in the United States and Europe.
The Inspire II feasibility study enrollments were completed in October 2010 and the follow-up phase of the study is ongoing. The Inspire II system demonstrated significant and sustained reductions in sleep apnea episodes in a select group of OSA patients.
